|
WO2010137018A1
(en)
|
2009-05-27 |
2010-12-02 |
Atir Holding S.A. |
Piperazine, piperidine and tetrahydropyridine derivatives and their pharmaceutical use
|
|
KR101178181B1
(ko)
*
|
2010-09-17 |
2012-09-19 |
대한민국(농촌진흥청장) |
신규한 항생활성 화합물 및 그 화합물을 포함하는 항생 조성물
|
|
WO2012049555A1
(en)
|
2010-10-13 |
2012-04-19 |
Lupin Limited |
Spirocyclic compounds as voltage-gated sodium channel modulators
|
|
EP2729149A4
(en)
*
|
2011-07-06 |
2015-01-07 |
Glaxo Group Ltd |
BLOCKERS OF VOLTAGE-DEPENDENT SODIC CHANNELS
|
|
JP6014155B2
(ja)
|
2011-10-31 |
2016-10-25 |
ゼノン・ファーマシューティカルズ・インコーポレイテッドＸｅｎｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｃ． |
ビアリールエーテルスルホンアミドおよび治療剤としてのそれらの使用
|
|
US9630929B2
(en)
|
2011-10-31 |
2017-04-25 |
Xenon Pharmaceuticals Inc. |
Benzenesulfonamide compounds and their use as therapeutic agents
|
|
HK1203412A1
(en)
|
2011-12-28 |
2015-10-30 |
Global Blood Therapeutics, Inc. |
Substituted heteroaryl aldehyde compounds and methods for their use in increasing tissue oxygenation
|
|
WO2013102142A1
(en)
|
2011-12-28 |
2013-07-04 |
Global Blood Therapeutics, Inc. |
Substituted benzaldehyde compounds and methods for their use in increasing tissue oxygenation
|
|
SG11201408284VA
(en)
|
2012-05-22 |
2015-02-27 |
Xenon Pharmaceuticals Inc |
N-substituted benzamides and their use in the treatment of pain
|
|
US10071957B2
(en)
|
2012-07-06 |
2018-09-11 |
Genentech, Inc. |
N-substituted benzamides and methods of use thereof
|
|
WO2014028829A1
(en)
*
|
2012-08-16 |
2014-02-20 |
The Scripps Research Institute |
Novel kappa opioid ligands
|
|
EP2974730B1
(en)
*
|
2013-03-14 |
2018-01-31 |
Daiichi Sankyo Company, Limited |
Drug for respiratory diseases
|
|
US9550775B2
(en)
|
2013-03-14 |
2017-01-24 |
Genentech, Inc. |
Substituted triazolopyridines and methods of use thereof
|
|
US8952171B2
(en)
|
2013-03-15 |
2015-02-10 |
Global Blood Therapeutics, Inc. |
Compounds and uses thereof for the modulation of hemoglobin
|
|
US9458139B2
(en)
|
2013-03-15 |
2016-10-04 |
Global Blood Therapeutics, Inc. |
Compounds and uses thereof for the modulation of hemoglobin
|
|
MX2015010775A
(es)
|
2013-03-15 |
2016-04-25 |
Genentech Inc |
Benzoxazoles sustituidos y metodos para usarlos.
|
|
WO2014145040A1
(en)
|
2013-03-15 |
2014-09-18 |
Global Blood Therapeutics, Inc. |
Substituted aldehyde compounds and methods for their use in increasing tissue oxygenation
|
|
SG10201802911RA
(en)
|
2013-03-15 |
2018-05-30 |
Global Blood Therapeutics Inc |
Compounds and uses thereof for the modulation of hemoglobin
|
|
US10266551B2
(en)
|
2013-03-15 |
2019-04-23 |
Global Blood Therapeutics, Inc. |
Compounds and uses thereof for the modulation of hemoglobin
|
|
EP3919056B1
(en)
|
2013-03-15 |
2024-08-28 |
Global Blood Therapeutics, Inc. |
Compounds and uses thereof for the modulation of hemoglobin
|
|
CN105209469A
(zh)
*
|
2013-03-15 |
2015-12-30 |
全球血液疗法股份有限公司 |
化合物及其用于调节血红蛋白的用途
|
|
AP2015008718A0
(en)
|
2013-03-15 |
2015-09-30 |
Global Blood Therapeutics Inc |
Compounds and uses thereof for the modulation of hemoglobin
|
|
US10005720B2
(en)
|
2013-04-05 |
2018-06-26 |
North Carolina Central University |
Compounds useful for the treatment of metabolic disorders and synthesis of the same
|
|
EA202092627A1
(ru)
|
2013-11-18 |
2021-09-30 |
Глобал Блад Терапьютикс, Инк. |
Соединения и их применения для модуляции гемоглобина
|
|
CR20160296A
(es)
|
2013-11-27 |
2016-09-20 |
Genentech Inc |
Benzamidas sustituidas y métodos para usarlas
|
|
WO2015088864A1
(en)
*
|
2013-12-09 |
2015-06-18 |
Merck Sharp & Dohme Corp. |
2-pyridyloxy-3-ester-4-ether orexin receptor antagonists
|
|
JP6045487B2
(ja)
*
|
2013-12-25 |
2016-12-14 |
シャープ株式会社 |
操作入力システム、電子機器、携帯端末、及び操作入力方法
|
|
ES2860648T5
(es)
|
2014-02-07 |
2024-11-27 |
Global Blood Therapeutics Inc |
Polimorfos cristalinos de la base libre de 2-hidroxi-6-((2-(1-isopropil-1H-pirazol-5-il)piridin-3-il)metoxi)benzaldehído
|
|
CA2936886A1
(en)
*
|
2014-02-27 |
2015-08-03 |
Merck Patent Gmbh |
Heterocyclic compounds as nav channel inhibitors and uses thereof
|
|
TW201623264A
(zh)
|
2014-03-29 |
2016-07-01 |
魯賓有限公司 |
作為電位閘控鈉通道調節劑之磺胺化合物
|
|
CN106715418A
(zh)
|
2014-07-07 |
2017-05-24 |
基因泰克公司 |
治疗化合物及其使用方法
|
|
WO2016021742A1
(en)
|
2014-08-07 |
2016-02-11 |
Takeda Pharmaceutical Company Limited |
Heterocyclic compounds as ep4 receptor antagonists
|
|
JP2018520107A
(ja)
|
2015-05-22 |
2018-07-26 |
ジェネンテック， インコーポレイテッド |
置換ベンズアミド及びその使用方法
|
|
EP3341353A1
(en)
|
2015-08-27 |
2018-07-04 |
Genentech, Inc. |
Therapeutic compounds and methods of use thereof
|
|
TW201722938A
(zh)
|
2015-09-04 |
2017-07-01 |
魯賓有限公司 |
作為電位閘控鈉通道調節子之磺醯胺化合物
|
|
CN108290881B
(zh)
|
2015-09-28 |
2021-12-07 |
健泰科生物技术公司 |
治疗性化合物和其使用方法
|
|
US10899732B2
(en)
|
2015-11-25 |
2021-01-26 |
Genentech, Inc. |
Substituted benzamides useful as sodium channel blockers
|
|
US11020382B2
(en)
|
2015-12-04 |
2021-06-01 |
Global Blood Therapeutics, Inc. |
Dosing regimens for 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde
|
|
KR20180086259A
(ko)
|
2016-02-03 |
2018-07-30 |
상하이 하이옌 파마슈티컬 테크놀로지 컴퍼니, 리미티드 |
헤테로 고리로 치환된 n-설포닐벤즈아미드 유도체, 이의 제조 방법과 약학적 용도
|
|
EP3854782A1
(en)
|
2016-03-30 |
2021-07-28 |
Genentech, Inc. |
Substituted benzamides and methods of use thereof
|
|
TWI825524B
(zh)
|
2016-05-12 |
2023-12-11 |
美商全球血液治療公司 |
用於合成2-羥基-6-((2-(1-異丙基-1h-吡唑-5-基)-吡啶-3-基)甲氧基)苯甲醛之方法
|
|
TW202332423A
(zh)
|
2016-10-12 |
2023-08-16 |
美商全球血液治療公司 |
包含2-羥基-6-((2-(1-異丙基-1h-吡唑-5-基)吡啶-3-基)甲氧基)-苯甲醛之片劑
|
|
AU2017347549A1
(en)
|
2016-10-17 |
2019-05-02 |
Genentech, Inc. |
Therapeutic compounds and methods of use thereof
|
|
WO2018163077A1
(en)
|
2017-03-08 |
2018-09-13 |
Lupin Limited |
Indanyl compounds as voltage gated sodium channel modulators
|
|
JP2020511511A
(ja)
|
2017-03-24 |
2020-04-16 |
ジェネンテック， インコーポレイテッド |
ナトリウムチャネル阻害剤としての４−ピペリジン−ｎ−（ピリミジン−４−イル）クロマン−７−スルホンアミド誘導体
|
|
AR114263A1
(es)
|
2018-02-26 |
2020-08-12 |
Genentech Inc |
Compuestos terapéuticos y métodos para utilizarlos
|
|
WO2019191702A1
(en)
|
2018-03-30 |
2019-10-03 |
F. Hoffmann-La Roche Ag |
Substituted hydro-pyrido-azines as sodium channel inhibitors
|
|
TW202003490A
(zh)
|
2018-05-22 |
2020-01-16 |
瑞士商赫孚孟拉羅股份公司 |
治療性化合物及其使用方法
|
|
EP3860975B1
(en)
|
2018-10-01 |
2023-10-18 |
Global Blood Therapeutics, Inc. |
Modulators of hemoglobin for the treatment of sickle cell disease
|
|
CN109796402A
(zh)
*
|
2018-12-28 |
2019-05-24 |
京博农化科技有限公司 |
一种烟嘧磺隆中间体2-氯-n，n-二甲基烟酰胺的制备方法
|
|
KR102845511B1
(ko)
*
|
2019-02-08 |
2025-08-12 |
삼성디스플레이 주식회사 |
축합환 화합물 및 이를 포함한 유기 발광 소자
|
|
WO2020179859A1
(ja)
|
2019-03-06 |
2020-09-10 |
第一三共株式会社 |
ピロロピラゾール誘導体
|